CalciMedica, Inc. Common Stock (CALC)

CalciMedica, Inc. Common Stock (CALC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $8.7M; returns 1 day +7.0%, 1 week +18.3%, 1 year -92.0%.

CalciMedica Inc. is a clinical-stage biopharmaceutical company primarily focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic diseases. The company's lead product candidate is Auxora™, a potent and selective small molecule CRAC channel inhibitor.

Groups CALC belongs to

• Healthcare
• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Biopharmaceutical
• Clinical Stage
• Life Sciences
• Chronic Inflammatory Diseases
• Unmet Medical Needs
• Immunotherapy
• R&D

CALC financial model: income statement, cash flow and balance sheet